UConn-Developed Diagnostic Test for Infectious Diseases Reaches Licensing Deal
The method enables simple, rapid detection of SARS-CoV-2 and other diseases.
(Getty Images) Copy Link
A simple, low-cost method of detecting infectious diseases developed by researchers at UConn has reached a licensing deal with Vault Medical Services.
In March 2020, researchers in the Department of Biomedical Engineering a shared department in the schools of Dental Medicine, Medicine, and Engineering began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including HIV and the novel coronavirus (SARS-CoV-2).
Led by associate professor Changchun Liu, the “All-In-One-Dual CRISPR-Cas12a” (AIOD-CRISPR) method enables simple, rapid, ultrasensitive, visual detection of SARS-CoV-2, intended for use at home or in small clinics.